Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maxigesic for reduction of opioid use in IV-PCA after laparoscopic gastrectomy
KCT0010512Phase 4Completed
- Sponsor
- Kyongbo Pharmaceutical Co., Ltd
- Start
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in postoperative pain comparing Maxigesic arm with Placebo arm (2 arms). Primary endpoint: Cumulative dose of oxycodone administered via IV-PCA. Started Jun 2025; status: completed.
02
Drugs
acetaminophen + ibuprofen
03
Conditions
postoperative pain
Beyond the preview
Go deeper on KCT0010512.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0010512.